Grup Moehs
Referent a nivell mundial
En un mercat de ràpid creixement i alta competitivitat, el Grup MOEHS ha progressat convertint-se en un dels actors principals a nivell mundial.
ELS FACTORS CLAU QUE CONFIRMEN AQUESTA TRAJECTÒRIA SÓN:
Consolidació d'una àmplia gamma de productes amb diferents activitats terapèutiques: des de mucolitics fins a ß-blocants.
Ampliació contínua de la nostra llista de APIs.
Òptim equilibri entre costos i serveis oferts.
Capacitat de comprensió de les necessitats transmeses pels clients per a traslladar-les a la nostra gamma.
Suport documental i regulador.
Llista de Productes
| Nom del producte | Cas nº | Categoria terapèutica | Dades Reglamentàries | Farmacopees | Planta de producció |
|---|---|---|---|---|---|
| CLOPERASTINE FENDIZOATE | 85187-37-7 | CNS Antitussive Antihystaminic | TP | Japanese Pharmacopoeia | |
| EDOXABAN TOSYLATE (**) | 1229194-11-9 | Oral anticoagulant Validation | DMF | ||
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | DMF | ||
| LEVOBUPIVACAINE HCl | 27262-48-2 | Local AnestheticAntiarrhythmic | DMF | ||
| NORADRENALINE TARTRATE | 108341-18-0 | Cardiovascular | TP | USP / Ph. Eur. | |
| REMIMAZOLAM BESYLATE (**) | 308242-62-8 | Sedation General Anesthesia | DMF | ||
| RIMEGEPANT SULFATE (**) | 1374024-48-2 | Acute migraine | DMF | ||
| RIVAROXABAN | 366789-02-8 | Oral anticoagulant | CEP, DMF | Ph. Eur. | |
| SITAGLIPTIN PHOSPHATE | 654671-77-9 | Antidiabetic | DMF | USP / Ph. Eur. | |
| ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
| AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
| AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| BUTALBITAL | (1953-33-9) | Hypnotic - Sedative | DMF Type II | USP | CFB |
| CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
| CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | In house | BCN |
| CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
| CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
| CHLORALHYDRATE | 302-17-0 | Hypnotic - Sedative | TP | Ph. Eur., USP | CFB |
| CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
| CINCHOPHEN | 132-60-5 | Analgesic - antipyretic | ASMF (CTD) | Ph. Eur. | CFB |
| DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
| DOMIPHEN BROMIDE | 538-71-6 | Disinfectant | TP | BP | CFB |
| DOXAZOSIN MESYLATE | 77883-43-3 | Antihypertensive | CEP | Ph. Eur. | CFB |
| DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
| FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
| LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, JDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & M. BCN |
| LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
| MAGNESIUM LACTATE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
| MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur 11 BP 2013 | BENECHIM |
| MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| METHENAMINE HIPPURATE | 5714-73-8 | Antibacterial (urinary) | DMF Type II | USP | CFB |
| METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
| METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
| NIKETHAMIDE | 59-26-7 | Respiratory analeptic | ASMF (CTD) | Ph. Eur. | CFB |
| PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| PENTOBARBITAL | 76-74-4 | Anesthetic - Euthanasia - Hypnotic - Sedative | ASMF (CTD) | Ph. Eur. | CFB |
| PENTOBARBITAL SODIUM | 57-33-0 | Anesthetic - Euthanasia - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL | 50-06-6 | Anticonvulsant - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL SODIUM | 57-30-7 | Anticonvulsant - Hypnotic - Sedative | - | Ph. Eur., USP | CFB |
| PHENTERMINE HCL | 1197-21-3 | Appetite suppressant | DMF Type II | USP | CFB |
| PICLOXIDINE DIHYDROCHLORIDE | 19803-62-4 | Antiseptic (eye drops) | ASMF (CTD) | Ph. Eur. | CFB |
| PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
| QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
| ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
| SECOBARBITAL SODIUM | 309-43-3309-43-3 | Hypnotic - Sedative | ASMF (CTD) | BP 93 | CFB |
| SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| TAMOXIFEN CITRATE | 54965-24-1 | Antiestrogen - Antineoplastic (hormonal) | CEP, ASMF (CTD) | Ph. Eur., USD, Ph. Jap. | CFB |
| TERAZOSIN HCL DIHYDRATE | 70024-40-7 | Antihypertensive | CEP | Ph. Eur. | CFB |
| THIOPENTAL SODIUM & SODIUM CARBONATE STERILE | 71-73-8 | Anesthetic (intravenous) - Narcotic | CEP | Ph. Eur. | CFB |
| TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
| VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
| XYLOMETAZOLINE HCL | 1218-35-5 | Decongestant – Rhinological therapeutic - Vasoconstrictor | CEP | Ph. Eur. | CFB |
| 4(6)-PROPYL-2- THIOURACIL | 51-52-5 | Antihyper thyroid | ASMF (CTD), DMF Type II | Ph. Eur., USP | CFB |
Productos en fase final de desarrollo
| Nom del producte | Cas nº | Categoria terapèutica | Dades Reglamentàries | Farmacopees | Planta de producció |
|---|---|---|---|---|---|
| CLOPERASTINE FENDIZOATE | 85187-37-7 | CNS Antitussive Antihystaminic | TP | Japanese Pharmacopoeia | |
| EDOXABAN TOSYLATE (**) | 1229194-11-9 | Oral anticoagulant Validation | DMF | ||
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | DMF | ||
| LEVOBUPIVACAINE HCl | 27262-48-2 | Local AnestheticAntiarrhythmic | DMF | ||
| NORADRENALINE TARTRATE | 108341-18-0 | Cardiovascular | TP | USP / Ph. Eur. | |
| REMIMAZOLAM BESYLATE (**) | 308242-62-8 | Sedation General Anesthesia | DMF | ||
| RIMEGEPANT SULFATE (**) | 1374024-48-2 | Acute migraine | DMF | ||
| RIVAROXABAN | 366789-02-8 | Oral anticoagulant | CEP, DMF | Ph. Eur. | |
| SITAGLIPTIN PHOSPHATE | 654671-77-9 | Antidiabetic | DMF | USP / Ph. Eur. | |
| ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
| AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
| AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| BUTALBITAL | (1953-33-9) | Hypnotic - Sedative | DMF Type II | USP | CFB |
| CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
| CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | In house | BCN |
| CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
| CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
| CHLORALHYDRATE | 302-17-0 | Hypnotic - Sedative | TP | Ph. Eur., USP | CFB |
| CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
| CINCHOPHEN | 132-60-5 | Analgesic - antipyretic | ASMF (CTD) | Ph. Eur. | CFB |
| DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
| DOMIPHEN BROMIDE | 538-71-6 | Disinfectant | TP | BP | CFB |
| DOXAZOSIN MESYLATE | 77883-43-3 | Antihypertensive | CEP | Ph. Eur. | CFB |
| DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
| FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
| LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, JDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & M. BCN |
| LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
| MAGNESIUM LACTATE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
| MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur 11 BP 2013 | BENECHIM |
| MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| METHENAMINE HIPPURATE | 5714-73-8 | Antibacterial (urinary) | DMF Type II | USP | CFB |
| METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
| METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
| NIKETHAMIDE | 59-26-7 | Respiratory analeptic | ASMF (CTD) | Ph. Eur. | CFB |
| PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| PENTOBARBITAL | 76-74-4 | Anesthetic - Euthanasia - Hypnotic - Sedative | ASMF (CTD) | Ph. Eur. | CFB |
| PENTOBARBITAL SODIUM | 57-33-0 | Anesthetic - Euthanasia - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL | 50-06-6 | Anticonvulsant - Hypnotic - Sedative | CEP | Ph. Eur., USP | CFB |
| PHENOBARBITAL SODIUM | 57-30-7 | Anticonvulsant - Hypnotic - Sedative | - | Ph. Eur., USP | CFB |
| PHENTERMINE HCL | 1197-21-3 | Appetite suppressant | DMF Type II | USP | CFB |
| PICLOXIDINE DIHYDROCHLORIDE | 19803-62-4 | Antiseptic (eye drops) | ASMF (CTD) | Ph. Eur. | CFB |
| PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
| QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
| ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
| SECOBARBITAL SODIUM | 309-43-3309-43-3 | Hypnotic - Sedative | ASMF (CTD) | BP 93 | CFB |
| SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| TAMOXIFEN CITRATE | 54965-24-1 | Antiestrogen - Antineoplastic (hormonal) | CEP, ASMF (CTD) | Ph. Eur., USD, Ph. Jap. | CFB |
| TERAZOSIN HCL DIHYDRATE | 70024-40-7 | Antihypertensive | CEP | Ph. Eur. | CFB |
| THIOPENTAL SODIUM & SODIUM CARBONATE STERILE | 71-73-8 | Anesthetic (intravenous) - Narcotic | CEP | Ph. Eur. | CFB |
| TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
| VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
| XYLOMETAZOLINE HCL | 1218-35-5 | Decongestant – Rhinological therapeutic - Vasoconstrictor | CEP | Ph. Eur. | CFB |
| 4(6)-PROPYL-2- THIOURACIL | 51-52-5 | Antihyper thyroid | ASMF (CTD), DMF Type II | Ph. Eur., USP | CFB |
| Nombre del producto | CAS N° | Categoría terapéutica | Disponibilidad | Datos regulatorios | Farmacopea |
|---|---|---|---|---|---|
| EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF | |
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF | |
| LEVOBUPIVACAINE HCL (**) | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | TP | |
| REMIMAZOLAM (**) | 308242-62-8 | Sedative | Laboratory batches | US-DMF | |
| RIVAROXABAN (**) | 366789-02-8 | Antibleeding agent | Validation batches | DMF | Ph. Eur. |
| SITAGLIPTIN HCL (**) | 862156-92-1 | Antidiabetic | Validation batches | DMF | |
| SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF | USP / Ph. Eur. |
| VILDAGLIPTIN (**) | 274901-16-5 | Antidiabetic | Validation batches | DMF |
(**) Moehs està treballant amb aquest compost amb finalitats experimentals, exclusivament dirigides a l’obtenció d’autoritzacions de comercialització dels medicaments genèrics dels nostres clients. No pretenem realitzar cap activitat contra cap protecció de patent vàlida, així com tampoc ens farem càrrec de les accions de tercers realitzades amb el compost proporcionat i sense el nostre coneixement contra aquesta protecció.
Productos en etapa inicial de desarrollo
| Product Name | CAS N° | Therapeutic Category | Additional Information | DMF / TP |
|---|---|---|---|---|
| ABROCITINIB (**) | 1622902-68-4 | Atopic Dermatitis | Laboratory batches | TP |
| ACETYL-DL-LEUCINE | 99-15-0 | Vertigo treatment | Kilo-lab batches | |
| BLARCAMESINE HCL (**) | 195615-84-0 | Anti-Alzheimer, Anti-Redd Syndrome | Laboratory batches | |
| DARIDOREXANT (**) | 1792993-84-0 | Insomnia | Laboratory batches | |
| DEUCRAVACITINIB (**) | 1609392-27-9 | Psoriasis | Laboratory batches | |
| ELAGOLIX SODIUM (**) | 832720-36-2 | Uterine Fibroids, Endometriosis pain | Validation batches | TP |
| FEZOLINETANT(**) | 1629229-37-3 | Menopausal Vasomotor symptoms | Laboratory batches | |
| LASMIDITAN SUCCINATE | 439239-92-6 | Antimigraine | Kilo - Lab batches | DMF |
| LEMBOREXANT (**) | 1369764-02-2 | Insomnia treatment | Laboratory batches | TP |
| LEVOCLOPERASTINE FENDIZOATE | 220329-19-1 | CNS Antitussive | Laboratory batches | |
| LINZAGOLIX(**) | 935283-04-8 | Uterine Fibroids. Endometriosis | Laboratory batches | |
| MAVACAMTEN (**) | 1642288-47-8 | Hypertrophic Cardiomyopathy | Kilo-lab batches | DMF |
| RELUGOLIX (**) | 737789-87-6 | Advanced prostate cancer. Uterine Fibroids, endometriosis | Kilo-lab batches | DMF |
| SOTAGLIFLOZIN (**) | 1018899-04-1 | Antidiabetic Heart failure treatment | Laboratory batches | |
| TIRBANIBULIN (**) | 897016-82-9 | Actinic Keratosis | Kilo - Lab batches | DMF |
| ZAVEGEPANT (**) | 1414976-20-7 | Acute migraine | laboratory batches | |
| VERICIGUAT (**) | 1350653-20-1 | Heart Failure | Kilo - lab batches | DMF |
Nuevos Productos en evaluación
| Product Name | CAS N° | Brand Name | Therapeutic Category | Galenic Form |
|---|---|---|---|---|
| MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | capsules | |
| VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | tablets |
